题目详情
当前位置:首页 > 职业培训考试
题目详情:
发布时间:2024-07-01 22:15:15

[不定项选择题]共用题干 Cancer Drug Trials Often Halted Early
An increasing number of clinical trials for new cancer treatments are being halted before the risks and benefits have been fully evaluated,say Italian researchers,who warn that this growing trend could put patients at risk of harm from new therapies rushed into use.
The researchers looked at 25 randomized,controlled clinical trials that were stopped ear-ly because the treatments had started to show benefit to patients.
“When we analyzed 25 trials over a 10-year period between 1997 and 2007,we found a consistent increase in prematurely stopped trials一more than 50 percent were stopped within the last three years,”study co-author Giovanni Apolone said at a news conference Tuesday.
Of 14 trials halted early and published between 2005 and 2007,the researchers found that 11(79 percent)of them were used to support drug approval applications submitted to the European Medicines Agency and the U.S.Food and Drug Administration.
“This suggests a strong commercial component in stopping trials prematurely.In fact, this strategy could guarantee quicker access to the market for companies.On the other hand, a quicker clinical drug development may lead to an ‘immature’benefit/risk balance of new drugs,”Apolone said.
He and his colleagues“are aware that trials stopped early because they are showing ben-efit may result in identification of promising new treatments for patients.However,findings obtained following this strategy should be considered to be preliminary results that require subsequent confirmation.”
It can take several years for the long-term benefits or harmful side effects of a new treat-ment to become apparent, Apolone noted, but the average duration(持续时间)of the 25 studies he and his colleagues analyzed was 30 months,with a range from 12 to 64 months.
They also found that at the time five of the studies were stopped,they'd enrolled less than 40 percent of the total number of patients planned for final analysis.
“Clinical trials need to stop early for superior benefit whenever there's proof beyond rea- sonable doubt that the new treatment really is superior.That would be an ethical obligation,” Stuart Pocock,a professor of medical statistics at the London School of Hygiene and Tropi-cal Medicine in the United Kingdom,said at the news conference.“However,too many trials are stopped early claiming efficacy(功效)without strong evidence being available.” The trials were stopped early because the treatments proved to be of no value.
A.Right
B.Wrong
C.Not mentioned

更多"[不定项选择题]共用题干 Cancer Drug Trials Of"的相关试题:

[不定项选择题]共用题干 Cancer Drug Trials Often Halted Early
An increasing number of clinical trials for new cancer treatments are being halted before the risks and benefits have been fully evaluated,say Italian researchers,who warn that this growing trend could put patients at risk of harm from new therapies rushed into use.
The researchers looked at 25 randomized,controlled clinical trials that were stopped ear-ly because the treatments had started to show benefit to patients.
“When we analyzed 25 trials over a 10-year period between 1997 and 2007,we found a consistent increase in prematurely stopped trials一more than 50 percent were stopped within the last three years,”study co-author Giovanni Apolone said at a news conference Tuesday.
Of 14 trials halted early and published between 2005 and 2007,the researchers found that 11(79 percent)of them were used to support drug approval applications submitted to the European Medicines Agency and the U.S.Food and Drug Administration.
“This suggests a strong commercial component in stopping trials prematurely.In fact, this strategy could guarantee quicker access to the market for companies.On the other hand, a quicker clinical drug development may lead to an ‘immature’benefit/risk balance of new drugs,”Apolone said.
He and his colleagues“are aware that trials stopped early because they are showing ben-efit may result in identification of promising new treatments for patients.However,findings obtained following this strategy should be considered to be preliminary results that require subsequent confirmation.”
It can take several years for the long-term benefits or harmful side effects of a new treat-ment to become apparent, Apolone noted, but the average duration(持续时间)of the 25 studies he and his colleagues analyzed was 30 months,with a range from 12 to 64 months.
They also found that at the time five of the studies were stopped,they'd enrolled less than 40 percent of the total number of patients planned for final analysis.
“Clinical trials need to stop early for superior benefit whenever there's proof beyond rea- sonable doubt that the new treatment really is superior.That would be an ethical obligation,” Stuart Pocock,a professor of medical statistics at the London School of Hygiene and Tropi-cal Medicine in the United Kingdom,said at the news conference.“However,too many trials are stopped early claiming efficacy(功效)without strong evidence being available.” Some of the trials were too short to show their long-term effects.
A.Right
B.Wrong
C.Not mentioned

我来回答:

购买搜题卡查看答案
[会员特权] 开通VIP, 查看 全部题目答案
[会员特权] 享免全部广告特权
推荐91天
¥36.8
¥80元
31天
¥20.8
¥40元
365天
¥88.8
¥188元
请选择支付方式
  • 微信支付
  • 支付宝支付
点击支付即表示同意并接受了《购买须知》
立即支付 系统将自动为您注册账号
请使用微信扫码支付

订单号:

请不要关闭本页面,支付完成后请点击【支付完成】按钮
恭喜您,购买搜题卡成功
重要提示:请拍照或截图保存账号密码!
我要搜题网官网:https://www.woyaosouti.com
我已记住账号密码